APA (7th ed.) Citation

L, R. S., R, R., W, O., N, S., & R, S. (2018). Prostate-specific antigen doubling time is a significant predictor of overall and disease-free survival in patients with prostate adenocarcinoma treated with brachytherapy. Brachytherapy, 17(6), 874. https://doi.org/10.1016/j.brachy.2018.07.008

Chicago Style (17th ed.) Citation

L, Resende Salgado, Rhome R, Oh W, Stone N, and Stock R. "Prostate-specific Antigen Doubling Time Is a Significant Predictor of Overall and Disease-free Survival in Patients with Prostate Adenocarcinoma Treated with Brachytherapy." Brachytherapy 17, no. 6 (2018): 874. https://doi.org/10.1016/j.brachy.2018.07.008.

MLA (9th ed.) Citation

L, Resende Salgado, et al. "Prostate-specific Antigen Doubling Time Is a Significant Predictor of Overall and Disease-free Survival in Patients with Prostate Adenocarcinoma Treated with Brachytherapy." Brachytherapy, vol. 17, no. 6, 2018, p. 874, https://doi.org/10.1016/j.brachy.2018.07.008.